February 12, 2014
The Japanese Society of Hypertension (JSH) announced on February 7 that it will retract a sub-analysis paper of SMART, a clinical study on Novartis Pharma’s hypertension drug Diovan (valsartan), from its journal Hypertension Research. The decision was made following a...read more